All In Biotech

Drug Trial Radar · NCT02374931

18F-FES PET/CT in Imaging Patients With Desmoid Tumors

Pilot Investigation of 18F-FES PET/CT Imaging of Desmoid Tumors

Last checked: Nov 20, 2026Latest source record: Oct 3, 2019 (this record)Source: ClinicalTrials.govMethods & limitations

Terminated

Status

Terminated

Enrollment

3

Actual

Start

Apr 2015

Primary completion

Jul 2017

Study completion Dec 2017

Sponsor

Lead sponsor
Vanderbilt-Ingram Cancer CenterAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
National Cancer Institute (NCI)
First posted
Mar 2, 2015

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Early phase 1
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Diagnostic
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This pilot clinical trial studies fluorine (F)-18 16 alpha-fluoroestradiol (18F-FES) positron emission tomography (PET)/computed tomography (CT) in imaging patients with desmoid tumors. 18F-FES binds to estrogen receptors, which are present on desmoid tumors, and gives off radiation that may be detected by PET and CT scans. The PET/CT scan forms an image that may show where tumor cells with estrogen receptors can be found in the body.

Conditions

  • Deep Fibromatosis/Desmoid Tumor
  • Familial Adenomatous Polyposis

Interventions

  • F-18 16 Alpha-FluoroestradiolDrug

    Undergo 18F-FES PET/CT

  • Positron Emission TomographyProcedure

    Undergo 18F-FES PET/CT

  • Computed TomographyProcedure

    Undergo 18F-FES PET/CT

  • Laboratory Biomarker AnalysisOther

    Correlative studies

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Standard uptake value (SUV) measured as percent injected dose per ccTime frame: Initial visit, average within 24 hours of imaging

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Vanderbilt-Ingram Cancer Center

    Nashville, Tennessee

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.